1. Home
  2. RPTX

RPTX

Repare Therapeutics Inc.

Logo Repare Therapeutics Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.

Founded: 2016 Country:
Canada
Canada
Employees: N/A City: SAINT-LAURENT
Market Cap: 135.4M IPO Year: 2020
Target Price: $17.33 AVG Volume (30 days): 129.1K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.23 EPS Growth: N/A
52 Week Low/High: $3.08 - $13.85 Next Earning Date: 05-07-2024
Revenue: $51,133,000 Revenue Growth: -61.21%
Revenue Growth (this year): -8.33% Revenue Growth (next year): -39.43%

Share on Social Networks: